Bexsero

Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Fierce Pharma
vaccines
GSK
Pfizer
meningococcal disease
Menveo
Bexsero
Flag link:
GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report
GlaxoSmithKline weighs plan to develop vaccine against fast-spreading gonorrhea: report
Fierce Pharma
GSK
Bexsero
vaccines
STD
gonorrhea
Flag link:
GlaxoSmithKline revives Bexsero's meningitis B moms in renewed back-to-college TV push
GlaxoSmithKline revives Bexsero's meningitis B moms in renewed back-to-college TV push
Fierce Pharma
GSK
Bexsero
meningitis B
vaccines
drug ads
Flag link:
Pfizer's Trumenba just got closer to a new FDA nod. Can it catch up to GlaxoSmithKline's Bexsero?
Pfizer's Trumenba just got closer to a new FDA nod. Can it catch up to GlaxoSmithKline's Bexsero?
Fierce Pharma
GSK
Pfizer
meningococcal B
vaccines
Trumenba
Bexsero
Flag link:
Families sending kids to college get mixed messages on meningitis B vaccine
Families sending kids to college get mixed messages on meningitis B vaccine
Stat
meningitis B
vaccines
Trumenba
Bexsero
Flag link:
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Yahoo/Zacks.com
GSK
Triumeq
Tivicay
Anoro
Incruse
Menveo
Bexsero
Shingrix
Nucala
Flag link:
GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
GSK’s Bexsero, Shingrix to pass $1B sales mark by 2022: report
Fierce Pharma
GSK
Bexsero
Shingrix
vaccines
shingles
meningitis B
Flag link:
Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod
Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod
Fierce Pharma
Pfizer
Trumenba
GSK
Bexsero
Europe
vaccines
meningococcal B
Flag link:
GlaxoSmithKline Giving a Shot to Its Vaccines Business
GlaxoSmithKline Giving a Shot to Its Vaccines Business
Market Realist
GSK
vaccines
Novartis
M&A
Rotarix
Boostrix
Bexsero
Menveo
Flag link:
GSK to overtake Sanofi atop meningococcal vaccine market, report predicts
GSK to overtake Sanofi atop meningococcal vaccine market, report predicts
Fierce Pharma
GSK
Sanofi
vaccines
meningococcal disease
Menactra
Bexsero
MenABCWY
Flag link:
U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group B vaccines
U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group B vaccines
Yahoo
CDC
physicians
GSK
vaccines
Bexsero
Flag link:
Glaxo finally strikes UK deal for Bexsero that eluded Novartis
Glaxo finally strikes UK deal for Bexsero that eluded Novartis
BioPharma Dive
GSK
Novartis
Bexsero
UK
Flag link:
Approval pits Novartis meningococcal vaccine against Pfizer shot
Approval pits Novartis meningococcal vaccine against Pfizer shot
Medical Marketing and Media
Novartis
vaccines
meningococcal conjugate vaccine
Pfizer
Bexsero
Trumemba
Flag link:
FDA approves 2nd vaccine against meningitis strain
FDA approves 2nd vaccine against meningitis strain
Yahoo/AP
Novartis
meningitis
Bexsero
vaccines
Flag link:
Pfizer's MenB reach--and lead on Novartis--limited without ACIP nod
Pfizer's MenB reach--and lead on Novartis--limited without ACIP nod
Fierce Vaccines
Pfizer
Novartis
FDA
meningitis B
vaccines
Bexsero
Flag link:
Amid Bexsero negotiations, Novartis medical director slams U.K. vaccine assessment system
Amid Bexsero negotiations, Novartis medical director slams U.K. vaccine assessment system
Fierce Vaccines
Bexsero
Novartis
vaccines
UK
Flag link:
Novartis, Pfizer seek U.S. approval of meningitis vaccines
Novartis, Pfizer seek U.S. approval of meningitis vaccines
Yahoo/Reuters
Novartis
Pfizer
vaccines
FDA
meningitis
bivalent rLP2086
Bexsero
Flag link:
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Forbes
FDA
Novartis
Bexsero
vaccines
breakthrough therapies
meningitis B
Flag link:
FDA And Meningitis B: Picking Winners And Losers
FDA And Meningitis B: Picking Winners And Losers
Forbes
meningitis B
FDA
Novartis
vaccines
Bexsero
Pfizer
bivalent rLP2086
Flag link:
Students in California are still waiting for Novartis' Bexsero to arrive
Students in California are still waiting for Novartis' Bexsero to arrive
Fierce Vaccines
Novartis
Bexsero
meningitis B
Flag link:

Pages